Antiretroviral activity of ancestral TRIM5α

Journal of Virology

Volumn 82, Issue 5, 2008, Pages 2089-2096

  Goldschmidt, Valérie ^a   Ciuffi, Angela ^a   Ortiz, Millan ^a   Brawand, David ^b   Muñoz, Miguel ^a   Kaessmann, Henrik ^b   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPARTITE MOTIF PROTEIN 5;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BAYES THEOREM; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS STRAIN;

ANIMALS; EVOLUTION, MOLECULAR; HELA CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; PRIMATES; PROTEINS; RETROVIRIDAE;

CERCOPITHECIDAE; HOMINOIDEA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINAE; MURINE LEUKEMIA VIRUS; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 39749105375     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01828-07     Document Type: Article

References (43)

1. Bieniasz, P. D. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109-1115.
2. Bogerd, H. P., B. P. Doehle, H. L. Wiegand, and B. R. Cullen. 2004. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101:3770-3774.
3. Chatterji, U., M. D. Bobardt, P. Gaskill, D. Sheerer, H. Fox, and P. A. Gallay. 2006. Trim5α accelerates degradation of cytosolic capsid associated with productive HIV-1 entry. J. Biol. Chem. 281:37025-37033.
4. Goldschmidt, V., G. Bleiber, M. T. May, R. Martinez, M. Ortiz, and A. Telenti. 2006. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 3:54.
5. Goodman, M. 1999. The genomic record of Humankind's evolutionary roots. Am. J. Hum. Genet. 64:31-39.
6. Hatziioannou, T., D. Perez-Caballero, A. Yang, S. Cowan, and P. D. Bieniasz. 2004. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc. Natl. Acad. Sci. USA 101:10774-10779.
7. Huelsenbeck, J. P., and F. Ronquist. 2001. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755.
8. Javanbakht, H., P. An, B. Gold, D. C. Petersen, C. O'Huigin, G. W. Nelson, S. J. O'Brien, G. D. Kirk, R. Detels, S. Buchbinder, S. Donfield, S. Shulenin, B. Song, M. J. Perron, M. Stremlau, J. Sodroski, M. Dean, and C. Winkler. 2006. Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354:15-27.
9. Javanbakht, H., F. az-Griffero, M. Stremlau, Z. Si, and J. Sodroski. 2005. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5α. J. Biol. Chem. 280:26933- 26940.
10. Kaiser, S. M., H. Malik, and M. Emerman. 2007. Restriction of an extinct retrovirus by the human TRIM5α antiviral protein. Science 316:1756-1758.
11. Kaumanns, P., I. Hagmann, and M. T. Dittmar. 2006. Human TRIM5α mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants. Retrovirology 3:79.
12. Keckesova, Z., L. M. Ylinen, and G. J. Towers. 2004. The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. USA 101:10780- 10785.
13. Lee, Y. N., and P. D. Bieniasz. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS. Pathog. 3:e10.
14. Li, Y., X. Li, M. Stremlau, M. Lee, and J. Sodroski. 2006. Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 80:6738-6744.
15. Mangeat, B., P. Turelli, S. Liao, and D. Trono. 2004. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279:14481-14483.
16. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
17. Newman, R. M., L. Hall, M. Connole, G. L. Chen, S. Sato, E. Yuste, W. Diehl, E. Hunter, A. Kaur, G. M. Miller, and W. E. Johnson. 2006. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc. Natl. Acad. Sci. USA.
18. Ohkura, S., M. W. Yap, T. Sheldon, and J. P. Stoye. 2006. All three variable regions of the TRIM5α B30.2 domain can contribute to the specificity of the retrovirus restriction. J. Virol. 80:8554-8565.
19. Ortiz, M., G. Bleiber, R. Martinez, H. Kaessmann, and A. Telenti. 2006. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology 3:11.
20. Perron, M. J., M. Stremlau, M. Lee, H. Javanbakht, B. Song, and J. Sodroski. 2007. The human TRIM5α restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J. Virol. 81:2138-2148.
21. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, A. Guffanti, S. Minucci, P. G. Pelicci, and A. Ballabio. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-2151.
22. Rice, P., I. Longden, and A. Bleasby. 2000. EMBOSS: the European molecular biology open software suite. Trends Genet. 16:276-277.
23. Sakuma, R., J. A. Noser, S. Ohmine, and Y. Ikeda. 2007. Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat. Med. 13:631-635.
24. Sawyer, S. L., L. I. Wu, J. M. Akey, M. Emerman, and H. S. Malik. 2006. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5α in humans. Curr. Biol. 16:95-100.
25. Sawyer, S. L., L. I. Wu, M. Emerman, and H. S. Malik. 2005. Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. USA 102:2832-2837.
26. Schrofelbauer, B., D. Chen, and N. R. Landau. 2004. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101:3927-3932.
27. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
28. Song, B., B. Gold, C. O'Huigin, H. Javanbakht, X. Li, M. Stremlau, C. Winkler, M. Dean, and J. Sodroski. 2005. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5α exhibits lineage-specific length and sequence variation in primates. J. Virol. 79:6111-6121.
29. Song, B., H. Javanbakht, M. Perron, D. H. Park, M. Stremlau, and J. Sodroski. 2005. Retrovirus restriction by TRIM5α variants from Old World and New World primates. J. Virol. 79:3930-3937.
30. Speelmon, E. C., D. Livingston-Rosanoff, S. S. Li, Q. Vu, J. Bui, D. E. Geraghty, L. P. Zhao, and M. J. McElrath. 2006. Genetic association of the antiviral restriction factor TRIM5α with human immunodeficiency virus type 1 infection. J. Virol. 80:2463-2471.
31. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
32. Stremlau, M., M. Perron, M. Lee, Y. Li, B. Song, H. Javanbakht, F. az-Griffero, D. J. Anderson, W. I. Sundquist, and J. Sodroski. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor. Proc. Natl. Acad. Sci. USA 103:5514- 5519.
33. Stremlau, M., M. Perron, S. Welikala, and J. Sodroski. 2005. Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of human immunodeficiency virus restriction. J. Virol. 79:3139-3145.
34. Thornton, J. W. 2004. Resurrecting ancient genes: experimental analysis of extinct molecules. Nat. Rev. Genet. 5:366-375.
35. Williams, P. D., D. D. Pollock, B. P. Blackburne, and R. A. Goldstein. 2006. Assessing the accuracy of ancestral protein reconstruction methods. PLoS. Comput. Biol. 2:e69.
36. Xu, H., E. S. Svarovskaia, R. Barr, Y. Zhang, M. A. Khan, K. Strebel, and V. K. Pathak. 2004. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA 101:5652-5657.
37. Yang, Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
38. Yap, M. W., S. Nisole, C. Lynch, and J. P. Stoye. 2004. Trim5α protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. USA 101:10786-10791.
39. Yap, M. W., S. Nisole, and J. P. Stoye. 2005. A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction. Curr. Biol. 15:73-78.
40. Ylinen, L. M., Z. Keckesova, S. J. Wilson, S. Ranasinghe, and G. J. Towers. 2005. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5α alleles. J. Virol. 79:11580-11587.
41. Yohn, C. T., Z. Jiang, S. D. McGrath, K. E. Hayden, P. Khaitovich, M. E. Johnson, M. Y. Eichler, J. D. McPherson, S. Zhao, S. Paabo, and E. E. Eichler. 2005. Lineage-specific expansions of retroviral insertions within the genomes of African great apes but not humans and orangutans. PLoS. Biol. 3:e110.
42. Zhang, F., T. Hatziioannou, D. Perez-Caballero, D. Derse, and P. D. Bieniasz. 2006. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353:396-409.
43. Zheng, Y. H., and B. M. Peterlin. 2005. Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells. Retrovirology 2:25.